EQT Private Equity and Goldman Sachs Spend $8.5 Billion to Acquire Parexel

2021-07-04| M&ASpecial

EQT Private Equity and Goldman Sachs Spend $8.5 Billion to Acquire Parexel

by Daniel Ojeda

Share To

On July 2nd, EQT Private Equity, a Swedish firm part of EQT AB, announced it would team up with Goldman Sachs to acquire Parexel, a clinical research organization (CRO). They would buy it from its current owner Pamplona Capital Management for $8.5 billion. The announcement comes amid EQT Private Equity’s restructuring of its healthcare-related holdings.

GO Prime with only $1.49 now

SUBSCRIBE NOW

LATEST

Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships

2024-09-12

Illumina’s IVD Biomarker Test Becomes the First FDA-approved Pan-cancer Companion Diagnostics Kit

2024-09-11

Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi

2024-09-06

Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week

2024-09-06

Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery

2024-09-06

Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void

2024-09-05

Breaking New Ground for Clinical Trials with AI/ML Applications

2024-09-05

EVENT

2024-09-13

ESMO Congress 2024

Barcelona, Spain

2024-10-09

Medical Japan 2024 Tokyo

Tokyo, Japan

2024-10-10

BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2024

Tokyo, Japan

2024-10-15

BIO Investor Forum 2024

San Francisco, U.S.A.

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

GENE ONLINE|News &
Opinion
Blog